drugset / Trial / NCT07591233

Pre-incisional Infiltration With Ropivacaine Plus Triamcinolone for Relieving Postoperative Pain After Laparoscopic Surgery

NCT07591233

Recruiting 150 enrolled Beijing Tiantan Hospital
RandomizedSequentialQuadruple-blindPrevention

Summary

Incisional infiltration is the simplest, safest, and most effective anesthesia method for preventing incision pain after laparoscopic surgery, but even using long-acting local anesthetics, the effectiveness of postoperative analgesia can only last for a relatively short period of time. Studies have shown that up to 80% of patients experience postoperative pain following laparoscopic surgery due to inflammation caused by surgical incisions and surrounding tissues, necessitating pharmacological relief. Inflammatory mediators released from the soft tissues around laparoscopic incisions not only significantly alters the chemical microenvironment at the peripheral terminals of nociceptors, directly inducing pain, but also sensitizes afferent fibers, contributing to peripheral sensitization. Preemptive incisional infiltration using local anesthetics with corticosteroids which have potent local anti-inflammatory properties may play a key role in preventing or reducing postoperative pain. The objective of this trial is to determine whether preemptive incisional infiltration with ropivacaine plus triamcinolone is superior to ropivacaine alone in relieving postoperative pain for adults undergoing laparoscopic surgery. We also compare the effects of the two intervention measures on postoperative pain management, patient safety, and recovery quality.

Timeline

Start
2026-06-01
Primary completion
2027-03-10
Completion
2028-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 0.5 % Subcutaneous
Subject Ropivacaine Other / unclassified 1 % Subcutaneous
Subject Triamcinolone Other / unclassified 80 mg Subcutaneous

Indications